| Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer CG Willett, Y Boucher, E Di Tomaso, DG Duda, LL Munn, RT Tong, ... Nature medicine 10 (2), 145-147, 2004 | 2521 | 2004 |
| AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients TT Batchelor, AG Sorensen, E di Tomaso, WT Zhang, DG Duda, ... Cancer cell 11 (1), 83-95, 2007 | 2124 | 2007 |
| Angiogenesis in brain tumours RK Jain, E Di Tomaso, DG Duda, JS Loeffler, AG Sorensen, TT Batchelor Nature Reviews Neuroscience 8 (8), 610-622, 2007 | 1653 | 2007 |
| Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases F Winkler, SV Kozin, RT Tong, SS Chae, MF Booth, I Garkavtsev, L Xu, ... Cancer cell 6 (6), 553-563, 2004 | 1590 | 2004 |
| Lymphatic metastasis in the absence of functional intratumor lymphatics TP Padera, A Kadambi, E di Tomaso, CM Carreira, EB Brown, Y Boucher, ... Science 296 (5574), 1883-1886, 2002 | 1388 | 2002 |
| Cancer cells compress intratumour vessels TP Padera, BR Stoll, JB Tooredman, D Capen, E Tomaso, RK Jain Nature 427 (6976), 695-695, 2004 | 1073 | 2004 |
| Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood YS Chang, E di Tomaso, DM McDonald, R Jones, RK Jain, LL Munn Proceedings of the National Academy of Sciences 97 (26), 14608-14613, 2000 | 963 | 2000 |
| Herceptin acts as an anti-angiogenic cocktail Y Izumi, L Xu, E Di Tomaso, D Fukumura, RK Jain Nature 416 (6878), 279-280, 2002 | 911 | 2002 |
| Anti-vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions CG Lee, M Heijn, E di Tomaso, G Griffon-Etienne, M Ancukiewicz, C Koike, ... Cancer research 60 (19), 5565-5570, 2000 | 884 | 2000 |
| Role of tumor–host interactions in interstitial diffusion of macromolecules: cranial vs. subcutaneous tumors A Pluen, Y Boucher, S Ramanujan, TD McKee, T Gohongi, E Di Tomaso, ... Proceedings of the National Academy of Sciences 98 (8), 4628-4633, 2001 | 749 | 2001 |
| LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis CM Carreira, SM Nasser, E di Tomaso, TP Padera, Y Boucher, ... Cancer research 61 (22), 8079-8084, 2001 | 617 | 2001 |
| Efficacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fluorouracil in rectal cancer: a multidisciplinary phase II study CG Willett, DG Duda, E Di Tomaso, Y Boucher, M Ancukiewicz, ... Journal of Clinical Oncology 27 (18), 3020-3026, 2009 | 596 | 2009 |
| Phase II study of cediranib, an oral pan–vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma TT Batchelor, DG Duda, E di Tomaso, M Ancukiewicz, SR Plotkin, ... Journal of Clinical Oncology 28 (17), 2817-2823, 2010 | 578 | 2010 |
| Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double … J Baselga, SA Im, H Iwata, J Cortés, M De Laurentiis, Z Jiang, CL Arteaga, ... The Lancet Oncology 18 (7), 904-916, 2017 | 563 | 2017 |
| Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study AX Zhu, DV Sahani, DG Duda, E di Tomaso, M Ancukiewicz, OA Catalano, ... Journal of clinical oncology 27 (18), 3027-3035, 2009 | 558 | 2009 |
| Hearing improvement after bevacizumab in patients with neurofibromatosis type 2 SR Plotkin, AO Stemmer-Rachamimov, FG Barker, C Halpin, TP Padera, ... New England Journal of Medicine 361 (4), 358-367, 2009 | 549 | 2009 |
| Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain H Cadas, E di Tomaso, D Piomelli Journal of Neuroscience 17 (4), 1226-1242, 1997 | 537 | 1997 |
| Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal … CG Willett, Y Boucher, DG Duda, E Di Tomaso, LL Munn, RT Tong, ... Journal of clinical oncology: official journal of the American Society of …, 2005 | 501 | 2005 |
| A “vascular normalization index” as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients AG Sorensen, TT Batchelor, WT Zhang, PJ Chen, P Yeo, M Wang, ... Cancer research 69 (13), 5296-5300, 2009 | 427 | 2009 |
| Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic … T Hoshida, N Isaka, J Hagendoorn, E di Tomaso, YL Chen, B Pytowski, ... Cancer research 66 (16), 8065-8075, 2006 | 422 | 2006 |
